TheChek News Flow

>>> Up

* BP Raised to Overweight at Morgan Stanley

* BP ADRs Raised to Overweight at Morgan Stanley; PT $49.40

* Croda Raised to Overweight at Morgan Stanley; PT 3,350 pence

* Diageo Raised to Neutral at BNP Paribas; PT 1,450 pence

* Equinor Raised to Equal-Weight at Morgan Stanley; PT 388 kroner

* Equinor ADRs Raised to Equal-Weight at Morgan Stanley

* Evli Raised to Buy at Inderes; PT 25 euros

* Kosmos Energy Raised to Buy at Johnson Rice; PT $4.25

* Lanxess Raised to Overweight at JPMorgan; PT 18 euros

* Novonesis Raised to Buy at Citi; PT 415 kroner

* Prosus Raised to Overweight at Morgan Stanley; PT 51 euros

* Repsol Raised to Overweight at Morgan Stanley

* Roche Raised to Buy at Intron Health
* SIG Group Raised to Buy at UBS; PT 15 Swiss francs

* Stadler Rail Raised to Neutral at UBS; PT 20 Swiss francs

>>> Down

* ALK-Abello Cut to Hold at Nordea

* Galp Cut to Equal-Weight at Morgan Stanley

* Mondelez Cut to Neutral at Rothschild & Co Redburn; PT $55
* Shell Cut to Equal-Weight at Morgan Stanley

* Shell ADRs Cut to Equal-Weight at Morgan Stanley; PT $95.50

>>> Initiation

* AT&T Rated New Buy at William O'Neil

* Galderma Reinstated Buy at Citi; PT 165 Swiss francs

* Kingspan Rated New Outperform at RBC; PT 97 euros

* ProCredit Holding Rated New Buy at Berenberg; PT 15.50 euros

* Prosus ADRs Rated New Overweight at Morgan Stanley; PT $12

* Rocket Cos. Rated New Market Perform at Citizens
* Rockwool Rated New Sector Perform at RBC; PT 196 kroner

* Talanx Rated New Overweight at JPMorgan; PT 125 euros

* Vicore Pharma Rated New Buy at Guggenheim; PT 38 kronor

* WaterBridge Infrastructure Rated New Buy at William O'Neil

>>> Call
* Barclays Strategists Raise S&P 500 Target Despite Macro Risks

* Croda Upgraded to Overweight at Morgan Stanley on Pricing Power

* Lanxess Double-Upgrade at JPMorgan, See Short-Term Sector Upside

* Novonesis Double-Upgraded at Citi, Good Entry Point After Reset

* Roche Selloff Now Overdone, Upgraded to Buy at Intron Health